Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nanthealth Inc (NH)

Nanthealth Inc (NH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanthealth Inc 3000 RDU CENTER DRIVE SUITE 200 MORRISVILLE NC 27560 USA

www.nanthealth.com P: 855-949-6268

Description:

Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States.

Key Statistics

Overview:

Market Capitalization, $K 10,399
Enterprise Value, $K 132,309
Shares Outstanding, K 7,703
Annual Sales, $ 67,000 K
Annual Net Income, $ -67,780 K
Last Quarter Sales, $ 17,050 K
Last Quarter Net Income, $ -12,240 K
60-Month Beta 1.82
% of Insider Shareholders 61.30%
% of Institutional Shareholders 4.50%
Float, K 2,981
% Float 38.70%
Short Volume Ratio 0.57

Growth:

1-Year Return -84.75%
3-Year Return -96.59%
5-Year Return -97.32%
5-Year Revenue Growth -22.70%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.80 on 11/03/22
Latest Earnings Date 05/25/23
Earnings Per Share ttm -3.60
EPS Growth vs. Prev Qtr -18.18%
EPS Growth vs. Prev Year -18.18%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/16/22

NH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -39.82%
Profit Margin % -101.16%
Debt/Equity -1.19
Price/Sales 0.29
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -30.73
Interest Coverage -3.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar